Not applicableStudy completedNCT01053715What this trial is testingQuality of Life Study of Helixate NexGenWho this might be right forHemophilia A CSL Behring 78
Post-approval studies (Phase 4)Active Not RecruitingNCT06752850What this trial is testingInvestigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa ProphylaxisWho this might be right forHaemophilia A (Moderate or Severe)Hemophilia, ClassicHaemophilia+3 more Swedish Orphan Biovitrum 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07226206What this trial is testingA Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia AWho this might be right forHemophilia A Hoffmann-La Roche 5
Not applicableWithdrawnNCT02718677What this trial is testingPatient-reported Outcomes in Subjects Treated With ReFacto AF Routine ProphylaxisWho this might be right forHemophilia A Pfizer
Large-scale testing (Phase 3)UnknownNCT02930317What this trial is testingEvaluate Efficacy and Safety of Recombinant Factor VIII (rFVIII)Treatment of Severe or Moderately Severe Hemophilia AWho this might be right forHemophilia A Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Not applicableNot Yet RecruitingNCT06191068What this trial is testingCanadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With HemophiliaWho this might be right forHemophilia The Hospital for Sick Children 288
Not applicableStudy completedNCT01034904What this trial is testingHealth Related Quality of Life of Youth and Young Adults With Hemophilia AWho this might be right forHemophilia A CSL Behring 48
Early research (Phase 1)Study completedNCT02035605What this trial is testingAn Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B PatientsWho this might be right forHemophilia AHemophilia B Sanofi 51
Large-scale testing (Phase 3)Study completedNCT01174446What this trial is testingPivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B PatientsWho this might be right forHemophilia B Baxalta now part of Shire 86
Large-scale testing (Phase 3)Study completedNCT03569891What this trial is testingHOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B PatientsWho this might be right forHemophilia B CSL Behring 67
Post-approval studies (Phase 4)Study completedNCT01128881What this trial is testingIMMUNINE Pre-Treatment StudyWho this might be right forHemophilia B Baxalta now part of Shire 57
Large-scale testing (Phase 3)Looking for participantsNCT05611801What this trial is testingA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia BWho this might be right forHemophilia AHemophilia B Pfizer 100
Post-approval studies (Phase 4)Study completedNCT00357656What this trial is testingPhase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic SurgeryWho this might be right forHemophilia A Baxalta now part of Shire 85
Not applicableStudy completedNCT00936845What this trial is testingFemales With Severe or Moderate Hemophilia A or B: A Multi-Center StudyWho this might be right forHemophilia AHemophilia B Weill Medical College of Cornell University 22
Large-scale testing (Phase 3)WithdrawnNCT06297486What this trial is testingStudy of a Gene Therapy Treatment for Hemophilia AWho this might be right forHemophilia A Spark Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT03489291What this trial is testingDose Confirmation Trial of AAV5-hFIXco-PaduaWho this might be right forHemophilia B CSL Behring 3
Not applicableStudy completedNCT00936312What this trial is testingFemales With Severe or Moderate Hemophilia A or B: an International Multi-center StudyWho this might be right forHemophilia AHemophilia B Weill Medical College of Cornell University 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416What this trial is testingKN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without InhibitorsWho this might be right forHemophilia a and B Suzhou Alphamab Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT03587116What this trial is testingEvaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)Who this might be right forHemophilia BHemophilia A Pfizer 212
Testing effectiveness (Phase 2)Study completedNCT02554773What this trial is testingAn Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or BWho this might be right forHemophilia AHemophilia B Genzyme, a Sanofi Company 34